0.5500
+0.0100
+(1.85%)
At close: April 17 at 4:00:00 PM EDT
0.5291
-0.02
(-3.80%)
After hours: April 17 at 5:57:43 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
59,126
56,832
62,521
81,149
101,980
Cost of Revenue
37,995
37,382
45,253
47,695
53,400
Gross Profit
21,131
19,450
17,268
33,454
48,580
Operating Expense
31,546
35,393
30,788
27,000
30,722
Operating Income
-10,415
-15,943
-13,520
6,454
17,858
Net Non Operating Interest Income Expense
-6,102
-8,977
-11,303
-5,862
-6,715
Other Income Expense
-3,916
-12,007
-18,957
-2,516
-17,776
Pretax Income
-20,433
-36,927
-43,780
-1,924
-6,633
Tax Provision
-102
-59
-194
-74
-620
Net Income Common Stockholders
-20,334
-24,018
-41,009
875
-6,388
Diluted NI Available to Com Stockholders
-20,334
-24,018
-41,009
875
-6,388
Basic EPS
-2.33
-3.20
-6.08
0.20
-1.60
Diluted EPS
-2.33
-3.20
-6.08
0.20
-1.60
Basic Average Shares
9,099.8110
7,654.9700
6,746.9660
4,180.3400
4,180.3400
Diluted Average Shares
10,345.6440
8,900.8030
6,746.9660
5,325.9320
5,251.2370
Total Operating Income as Reported
-13,426
-27,045
-19,349
3,938
82
Total Expenses
69,541
72,775
76,041
74,695
84,122
Net Income from Continuing & Discontinued Operation
-20,334
-24,018
-41,009
875
-6,388
Normalized Income
-16,431.5634
-24,877.1889
-24,710.0164
573.0769
10,103.6635
Interest Income
298
--
--
3
36
Interest Expense
7,571
10,148
11,532
5,447
5,535
Net Interest Income
-6,102
-8,977
-11,303
-5,862
-6,715
EBIT
-12,862
-26,779
-32,248
3,523
-1,098
EBITDA
-10,959
-25,002
-29,915
6,267
1,979
Reconciled Cost of Revenue
37,995
37,382
45,253
47,695
53,400
Reconciled Depreciation
1,903
1,777
2,333
2,744
3,077
Net Income from Continuing Operation Net Minority Interest
-20,331
-36,868
-43,586
-1,850
-6,013
Total Unusual Items Excluding Goodwill
-3,919
-12,010
-18,960
-2,520
-17,779
Total Unusual Items
-3,919
-12,010
-18,960
-2,520
-17,779
Normalized EBITDA
-7,040
-12,992
-10,955
8,787
19,758
Tax Rate for Calcs
0
0
0
0
0.0001
Tax Effect of Unusual Items
-19.5634
-19.1889
-84.0164
-96.9231
-1,662.3365
12/31/2020 - 10/21/1992
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
WOK WORK Medical Technology Group LTD
0.4362
-9.18%
BSXC.VI Boston Scientific Corporation
84.40
-0.71%
NEOLA.ST Neola Medical AB (publ)
2.7200
+7.09%
6L6.SG Senseonics Holdings Inc
0.5264
+2.21%
SUN.L Surgical Innovations Group plc
0.5000
0.00%
941.MU Theraclion SA
0.1445
-0.69%
IHC.L Inspiration Healthcare Group plc
16.75
0.00%
1RC.SG Creo Medical Group PLC
0.1070
-4.46%
AT1.AX Atomo Diagnostics Limited
0.0200
0.00%
EPIS-B.ST Episurf Medical AB (publ)
0.1120
-2.44%